πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 677 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7824682

Cardiac myosin light chain kinase-specific antibodies and methods of detecting

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824681

Human monoclonal antibodies that specifically bind IGF-II

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824695

Delivery of proteins across polar epithelial cell layers

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825096

O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrug

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825126

Purine derivatives as A3 and A1 adenosine receptor agonists

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825216

Phenylanine derivatives

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820181

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of reco

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820174

T cell receptors and related materials and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820182

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in i

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820642

Nandrolone 17Ξ²-carbonates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7816087

Gene expressed in prostate cancer and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7811998

Novobiocin analogues as anticancer agents

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7812117

Vasostatin as marrow protectant

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807805

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803380

Compositions and methods for diagnosis and treatment of tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803614

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803913

Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies us

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794998

Primate T-lymphotropic viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795208

Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790735

Methanocarba cycloalkyl nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790473

Biofunctionalized quantum dots for biological imaging

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790764

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781445

Synthesis of indenoisoquinoliniums and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776883

Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted